LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.74 USD Market Closed
Market Cap: 45.8m USD

During the last 3 months LAVA Therapeutics NV insiders have not bought any shares, and sold 8.2m USD worth of shares. The stock price has increased by 12% over this period (open performance analysis).

The last transaction was made on Oct 17, 2025 by Gilde Healthcare Holding B.v. , who sold 1.7m USD worth of LVTX shares.

Last Transactions:
Gilde Healthcare Holding B.v.
$-1.7m
Gilde Healthcare Holding B.v.
Director
$-1m
Gilde Healthcare Holding B.v.
$-343.3k
Gilde Healthcare Holding B.v.
Director
$-73.4k
Gilde Healthcare Holding B.v.
$-77.3k
Gilde Healthcare Holding B.v.
Director
$-75.1k
Gilde Healthcare Holding B.v.
Director
$-45.5k
Versant Venture Capital Vi, L.p.
$-3.3m
Versant Venture Capital Vi, L.p.
$-527.9k
Versant Venture Capital Vi, L.p.
$-540.3k
Versant Venture Capital Vi, L.p.
$-471.8k
View All Transactions

During the last 3 months LAVA Therapeutics NV insiders have not bought any shares, and sold 8.2m USD worth of shares. The stock price has increased by 12% over this period (open performance analysis).

The last transaction was made on Oct 17, 2025 by Gilde Healthcare Holding B.v. , who sold 1.7m USD worth of LVTX shares.

Sold
0-3
months
8.2m USD
2
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

LAVA Therapeutics NV
Insider Trading Chart

LAVA Therapeutics NV
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

LAVA Therapeutics NV
Last Insider Transactions

Global
Insiders Monitor

LAVA Therapeutics NV
Glance View

Market Cap
45.8m USD
Industry
Biotechnology

LAVA Therapeutics NV operates as a biotechnology company, which develops immune oncology biopharmaceutical products. The company is headquartered in Utrecht, Utrecht and currently employs 55 full-time employees. The firm focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.

LVTX Intrinsic Value
2.55 USD
Undervaluation 32%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top